Neurodegenerative disease is an umbrella term for a range of conditions which primarily affect the neurons in the human brain. Neurons are the building blocks of the nervous system which includes the brain and spinal cord. Neurons normally don’t reproduce or replace themselves, so when they become damaged or die they cannot be replaced by the body. Examples of neurodegenerative diseases include Parkinson’s, Alzheimer’s, and Huntington’s disease. Neurodegenerative diseases are incurable and debilitating conditions that result in progressive degeneration and / or death of nerve cells. This causes problems with movement (called ataxias), or mental functioning (called dementias). Dementias are responsible for the greatest burden of neurodegenerative diseases, with Alzheimer’s representing approximately 60-70% of dementia cases. The report focuses on the Neurodegenerative Diseases market size, segment size (mainly covering product type, application, and geography), competitor landscape, recent status, and development trends. Furthermore, the report provides strategies for companies to overcome threats posed by COVID-19. Technological innovation and advancement will further optimize the performance of the product, enabling it to acquire a wider range of applications in the downstream market. Moreover, customer preference analysis, market dynamics (drivers, restraints, opportunities), new product release, impact of COVID-19, regional conflicts and carbon neutrality provide crucial information for us to take a deep dive into the Neurodegenerative Diseases market. Major Players in the Neurodegenerative Diseases market are: Amarin Bayer Asubio Pharmaceutical Yumanity Therapeutics UCB Addex Pharmaceutical Eisai Teva AstraZeneca Boehringer Ingelheim Pfizer Merck Alector Novartis H.Lundbeck A/S Bial Biogen Idec On the basis of types, the Neurodegenerative Diseases market is primarily split into: NMDA SSRIs Dopamine Inhibitors On the basis of applications, the market covers: Parkinson’s Disease Huntington Disease Amyotrophic Lateral Sclerosis Alzheimer’s Disease Major Regions or countries covered in this report: United States Europe China Japan India Southeast Asia Latin America Middle East and Africa Others Years considered for this report: Historical Years: 2017-2021 Base Year: 2021 Estimated Year: 2022 Forecast Period: 2022-2029
Table of Content 1 Neurodegenerative Diseases Market Overview 1.1 Product Overview and Scope of Neurodegenerative Diseases Market 1.2 Neurodegenerative Diseases Market Segment by Type 1.2.1 Global Neurodegenerative Diseases Market Sales and CAGR (%) Comparison by Type (2017-2029) 1.3 Global Neurodegenerative Diseases Market Segment by Application 1.3.1 Neurodegenerative Diseases Market Consumptio
